Citadel Advisors
IVDAW icon

Citadel Advisors’s Iveda Solutions Warrant IVDAW Stock Holding History

Citadel Advisors’s Portfolio IVDAW Stock Details IVDAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,490
Closed -$2.12K – 13794
2025
Q1 		$2.12K Sell
12,490
-10,122
-45% -$1.81K ﹤0.01% 14063
2024
Q4 		$4.73K Sell
22,612
-11,248
-33% -$934 ﹤0.01% 13906
2024
Q3 		$1.35K Buy
33,860
+15,388
+83% +$948 ﹤0.01% 13860
2024
Q2 		$831 Sell
18,472
-2,506
-12% -$269 ﹤0.01% 13904
2024
Q1 		$1.47K Buy
20,978
+8,038
+62% +$1.11K ﹤0.01% 14125
2023
Q4 		$1.11K Buy
12,940
+546
+4% +$70 ﹤0.01% 13873
2023
Q3 		$2.73K Sell
12,394
-2,825
-19% -$558 ﹤0.01% 13682
2023
Q2 		$3.65K Sell
15,219
-5,819
-28% -$1.49K ﹤0.01% 13672
2023
Q1 		$8.24K Buy
+21,038
New +$7.83K ﹤0.01% 13673

Other funds holding IVDAW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Citadel Advisors's IVDAW Position: Q2 2025 in Review

Citadel Advisors sold out of Iveda Solutions Warrant (IVDAW) in Q2 2025, closing a stake of 12,490 shares — an estimated $2.12K sold.

Citadel Advisors first reported a position in IVDAW in Q1 2023 and held it in 9 quarters. The position peaked at $8.24K in Q1 2023. 5 funds tracked by Wall St. Rank hold IVDAW as of Q2 2025.

  • Citadel Advisors reported no remaining Iveda Solutions Warrant position as of Q2 2025 after selling out during the quarter.
  • Citadel Advisors sold 12,490 Iveda Solutions Warrant shares in Q2 2025, an estimated $2.12K.
  • Citadel Advisors first reported a position in Iveda Solutions Warrant in Q1 2023 and held it in 9 quarters.
  • Citadel Advisors's Iveda Solutions Warrant position peaked at $8.24K in Q1 2023.
  • 5 funds tracked by Wall St. Rank held Iveda Solutions Warrant as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.